Prudential Financial
SION

Prudential Financial’s Sionna Therapeutics SION Stock Holding History

Prudential Financial’s Portfolio SION Stock Details SION Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-135,185
Closed -$2.35M – 2547
2025
Q2 		$2.35M Buy
135,185
+72,185
+115% +$946K ﹤0.01% 1306
2025
Q1 		$659K Buy
+63,000
New +$1.03M ﹤0.01% 1728

Other funds holding SION

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $352M AUM 220.14% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Prudential Financial's SION Position: Q3 2025 in Review

Prudential Financial sold out of Sionna Therapeutics (SION) in Q3 2025, closing a stake of 135,185 shares — an estimated $2.35M sold.

Prudential Financial first reported a position in SION in Q1 2025 and held it in 2 quarters. The position peaked at $2.35M in Q2 2025. 78 funds tracked by Wall St. Rank hold SION as of Q3 2025.

  • Prudential Financial reported no remaining Sionna Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Prudential Financial sold 135,185 Sionna Therapeutics shares in Q3 2025, an estimated $2.35M.
  • Prudential Financial first reported a position in Sionna Therapeutics in Q1 2025 and held it in 2 quarters.
  • Prudential Financial's Sionna Therapeutics position peaked at $2.35M in Q2 2025.
  • 78 funds tracked by Wall St. Rank held Sionna Therapeutics as of Q3 2025.

Based on Prudential Financial's 13F filing for Q3 2025, filed 13 Nov 2025.